Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Change in Acquisitions & Divestments (2010 - 2026)

Lemaitre Vascular (LMAT) reported Change in Acquisitions & Divestments of $140.6 million for Q1 2026, up 4585.77% on a QoQ basis from $3.0 million in Q4 2021.

Lemaitre Vascular (LMAT) has 6 years of Change in Acquisitions & Divestments data on file, last reported at $140.6 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $140.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $143.6 million (up 4685.77% YoY) and the FY2025 annual result came in at $585.1 million, up 590.1% from the prior year.
  • Change in Acquisitions & Divestments improved to $140.6 million in Q1 2026 per LMAT's latest filing, from $3.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $140.6 million in Q1 2026 and bottomed at $140.6 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Lemaitre Vascular 2.28 Bn 1.91 Bn 48.40 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 140.57 Mn
Mar 31, 2026 140.57 Mn
Dec 31, 2021 3.00 Mn
Dec 31, 2021 3.00 Mn
Dec 31, 2020 4.90 Mn
Dec 31, 2020 4.90 Mn
Jun 30, 2020 15.00 Mn
Jun 30, 2020 15.00 Mn
Mar 31, 2020 3.00 Mn
Mar 31, 2020 3.00 Mn
Dec 31, 2019 16.60 Mn
Dec 31, 2019 16.60 Mn
Sep 30, 2019 7.00 Mn
Sep 30, 2019 7.00 Mn
Dec 31, 2018 7.50 Mn
Dec 31, 2018 7.50 Mn
Dec 31, 2010 170,000.00
Dec 31, 2010 170,000.00
Sep 30, 2010 172,000.00
Sep 30, 2010 172,000.00